Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

201.17
+2.651.33%
Volume:57.29K
Turnover:11.55M
Market Cap:10.54B
PE:-53.38
High:203.18
Open:199.71
Low:199.71
Close:198.52
52wk High:260.19
52wk Low:112.90
Shares:52.38M
Float Shares:43.83M
Volume Ratio:0.65
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:126.49
PE(LYR):-54.63

Loading ...

Jan 18, 2022

Major Issues Report

8-K - Current report
Jan 18, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 23, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 16, 2021

Major Issues Report

Axsome Therapeutics, Inc.
Sep 16, 2021

Major Issues Report

8-K - Current report
Sep 14, 2021

Major Issues Report

Axsome Therapeutics, Inc.
Sep 14, 2021

Major Issues Report

8-K - Current report
Aug 23, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 13, 2021

Major Issues Report

8-K - Current report
Jun 15, 2021

Major Issues Report

8-K - Current report
Jun 08, 2021

Major Issues Report

8-K - Current report
May 11, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]